Search

everythinglearnresearchcommunity

for

Search:↓

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

5α-reductases increase epitestosterone's effect on androgen receptors.

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

5% ET-02 is a more effective and safe treatment for hair loss than current options.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

11-oxyandrogens are linked to excess hair growth in PCOS, but don't help diagnose it.

Diane and Androcur 10 improved acne and seborrhea in most women, and hirsutism and alopecia in about half.

Finasteride, a hair loss treatment, works better and is more stable when delivered through specially prepared gels, leading to increased hair growth.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Cyproterone acetate can effectively treat idiopathic hirsutism, but ethinyl oestradiol and lynoestrenol may not always reduce hair growth.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Topical estrogen helps hair growth in menopausal women with no major side effects.

Ursolic acid from Ochrosia elliptica leaves may help manage PCOS symptoms.

Testosterone increases seizure risk through its conversion to specific neurosteroids.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Localized estrogen treatments may improve skin quality with fewer risks than systemic hormone therapy.

DHEA therapy improves pubic hair growth and psychological well-being in young females with central adrenal insufficiency.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

The article's findings are uncertain and should be viewed with caution.

Some steroid-induced health issues in rodents improved after stopping treatment, but hair loss and eye problems did not.

Free testosterone is the most common hormone marker in PCOS, and age affects DHEAS levels.

Compounds 6f and 6g effectively stop prostate cancer cell growth without harming healthy cells.

The new drug delivery system improves exemestane's absorption and effectiveness.